LivaNova (LIVN) EPS (Weighted Average and Diluted) Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -19.74% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.20% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 88.89% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 47.37% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 106.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.66% |
| Dec 31, 2025 | -45.63% |
| Sep 30, 2025 | -18.33% |
| Jun 30, 2025 | 66.67% |
| Mar 31, 2025 | -670.51% |
| Dec 31, 2024 | 243.33% |
| Sep 30, 2024 | 528.57% |
| Jun 30, 2024 | 1,400.00% |
| Mar 31, 2024 | -657.14% |
| Dec 31, 2023 | 900.00% |
| Sep 30, 2023 | 93.03% |
| Jun 30, 2023 | -93.33% |
| Mar 31, 2023 | 133.33% |
| Dec 31, 2022 | 130.00% |
| Sep 30, 2022 | -139.29% |
| Jun 30, 2022 | 126.09% |
| Mar 31, 2022 | 109.52% |
| Dec 31, 2021 | 98.27% |
| Sep 30, 2021 | -180.00% |
| Jun 30, 2021 | 37.50% |
| Mar 31, 2021 | -181.82% |
| Dec 31, 2020 | -95.27% |
| Sep 30, 2020 | -145.45% |
| Jun 30, 2020 | -206.67% |
| Mar 31, 2020 | 348.39% |
| Dec 31, 2019 | 31.80% |
| Sep 30, 2019 | 540.00% |
| Jun 30, 2019 | -293.55% |
| Mar 31, 2019 | -186.11% |
| Dec 31, 2018 | -87.07% |
| Sep 30, 2018 | -126.32% |
| Jun 30, 2018 | -67.37% |
| Mar 31, 2018 | 33.33% |
| Dec 31, 2017 | -280.33% |
| Sep 30, 2017 | 338.46% |
| Jun 30, 2017 | 265.38% |
| Mar 31, 2017 | 132.53% |
| Dec 31, 2016 | -34.10% |
| Dec 31, 2015 | -384.30% |
| Oct 18, 2015 | -250.00% |
| Apr 24, 2015 | 0.00% |